Markets:

Overview

News

Currencies

International

Treasuries

Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

440.19 +12.00 (+2.80%)

Streaming Delayed Price Updated: 10:55 AM EST, Feb 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Medpace Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Which stocks are moving before the opening bell on Tuesday? ↗

July 22, 2025

The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 22, 2025

Via Benzinga

Top 2 Health Care Stocks You May Want To Dump This Quarter ↗

July 22, 2025

Via Benzinga

US Stocks Likely To Open On A Mixed Note Ahead Of Coca-Cola, GM, Lockheed Martin Earnings ↗

July 22, 2025

U.S. stock futures were fluctuating on Tuesday after ending on a mixed note on Monday. Futures of major benchmark indices were mixed.

Via Benzinga

Medpace Retail Trader Optimism Abounds As Stock Poised For Best Day Ever On Q2 Beat, Outlook ↗

July 22, 2025

Via Stocktwits

A Peek at Medpace Hldgs's Future Earnings ↗

July 18, 2025

Via Benzinga

Why Medpace Shares Are Trading Higher By 45%; Here Are 20 Stocks Moving Premarket ↗

July 22, 2025

Via Benzinga

Coca-Cola, General Motors And 3 Stocks To Watch Heading Into Tuesday ↗

July 22, 2025

US stock futures mixed, focus on Coca-Cola, GM, Farmer Bros. Medpace reports strong Q2 results and raises guidance.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 21, 2025

Via Benzinga

Get insights into the top gainers and losers of Monday's after-hours session. ↗

July 21, 2025

The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today.

Via Chartmill

Medpace Holdings Stock Soars After Company Tops Q2 Earnings Estimates, Raises 2025 Outlook ↗

July 21, 2025

Medpace Holdings shares are soaring in Monday's after-hours session after the company reported strong financial results for the second quarter and raised its full-year guidance.

Via Benzinga

Medpace (NASDAQ:MEDP) Reports Strong Q2, Stock Jumps 46%

July 21, 2025

Clinical research company Medpace Holdings (NASDAQ:MEDP) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 14.2% year on year to $603.3 million. The company’s...

Via StockStory

Medpace Holdings, Inc. Reports Second Quarter 2025 Results

July 21, 2025

From Medpace Holdings, Inc.

Via Business Wire

Earnings Scheduled For July 21, 2025 ↗

July 21, 2025

Via Benzinga

Medpace (MEDP) Q2 Earnings Report Preview: What To Look For

July 19, 2025

Clinical research company Medpace Holdings (NASDAQ:MEDP) will be reporting results this Monday after market hours. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence

Motley Fool Investors Look Back at the First Half of 2025 ↗

July 08, 2025

Via The Motley Fool

Topics Government World Trade

Reflecting On Drug Development Inputs & Services Stocks’ Q1 Earnings: Medpace (NASDAQ:MEDP)

June 24, 2025

Let’s dig into the relative performance of Medpace (NASDAQ:MEDP) and its peers as we unravel the now-completed Q1 drug development inputs & services earnings season.

Via StockStory

Medpace Holdings, Inc. to Report Second Quarter 2025 Financial Results on July 21, 2025

June 23, 2025

From Medpace Holdings, Inc.

Via Business Wire

1 Cash-Producing Stock on Our Watchlist and 2 to Think Twice About

June 23, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

Topics Intellectual Property

2 Reasons to Watch MEDP and 1 to Stay Cautious

June 18, 2025

Over the last six months, Medpace’s shares have sunk to $293, producing a disappointing 11.5% loss - a stark contrast to the S&P 500’s 1.7% gain. This may have investors wondering how to approach the...

Via StockStory

Topics Stocks

2 Small-Cap Stocks to Keep an Eye On and 1 to Think Twice About

June 16, 2025

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

3 Market-Beating Stocks to Target This Week

June 11, 2025

Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the...

Via StockStory

2 Profitable Stocks to Target This Week and 1 to Turn Down

June 05, 2025

A company with profits isn’t always a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Via StockStory

Is Medpace Stock Worth the Hype? Here's What Analysts Think. ↗

May 27, 2025

Via The Motley Fool

May 22, 2025

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...

Via StockStory

Hedge Funds Are Building A Towering Wall Of Bets Against Stocks ↗

May 21, 2025

After a sharp 23% rebound in the S&P 500 since April, hedge funds are now stacking record levels of bearish bets against stocks as investors question the staying power of the tariff-relief rally.

Via Benzinga

Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know

May 12, 2025

A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides...

Via StockStory

Topics Government Stocks World Trade

MEDP Q1 Earnings Call: Outperformance Driven by Revenue Upside, Cautious Outlook Amid Funding Uncertainty

May 10, 2025

Clinical research company Medpace Holdings (NASDAQ:MEDP) announced better-than-expected revenue in Q1 CY2025, with sales up 9.3% year on year to $558.6 million. The company’s full-year revenue guidance...

Via StockStory

Topics Economy

If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again? ↗

May 01, 2025

Medical stocks are usually considered defensive. But have they been too hammered by regulatory changes to hold up this year?

Via Investor's Business Daily

Topics Animal Testing Economy Government

Repligen (RGEN) Q1 Earnings: What To Expect

April 28, 2025

Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) will be announcing earnings results tomorrow morning. Here’s what to look for.

Via StockStory

Topics World Trade

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

All News about Medpace Holdings, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today